Drug Target Could Block Brain Inflammation Linked to Alzheimer's

Source: Science Daily - Top HealthBlocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery, published in the journal Brain, could help researchers repurpose existing drugs to treat conditions that include traumatic brain injury, Alzheimer's disease, Parkinson's disease, depression, and schizophrenia.